Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

The non-erythroid myeloblast count rule in myelodysplastic syndromes: fruitful or futile?

van Spronsen MF, Westers TM, Lissenberg-Witte BI, Wondergem M, Ossenkoppele GJ, van de Loosdrecht AA.

Haematologica. 2019 Dec;104(12):e547-e550. doi: 10.3324/haematol.2018.212563. Epub 2019 Apr 19. No abstract available.

2.

Validation of and proposals for refinements of the WHO 2016 classification for myelodysplastic syndromes.

van Spronsen MF, Westers TM, Rozema H, Ossenkoppele GJ, Kibbelaar RE, Hoogendoorn M, van de Loosdrecht AA.

Am J Hematol. 2017 Nov;92(11):E631-E634. doi: 10.1002/ajh.24867. Epub 2017 Aug 24. No abstract available.

3.

Response to letter commenting on: Prognostic relevance of morphological classification models for myelodysplastic syndromes in an era of the revised International Prognostic Scoring System.

van Spronsen MF, Witte BI, Ossenkoppele GJ, Westers TM, van de Loosdrecht AA.

Eur J Cancer. 2017 Feb;72:269-271. doi: 10.1016/j.ejca.2016.11.029. Epub 2017 Jan 2. No abstract available.

PMID:
28057399
4.

Prognostic relevance of morphological classification models for myelodysplastic syndromes in an era of the revised International Prognostic Scoring System.

van Spronsen MF, Ossenkoppele GJ, Westers TM, van de Loosdrecht AA.

Eur J Cancer. 2016 Mar;56:10-20. doi: 10.1016/j.ejca.2015.12.004. Epub 2016 Jan 19.

PMID:
26798967
5.

Improved risk stratification by the integration of the revised international prognostic scoring system with the myelodysplastic syndromes comorbidity index.

van Spronsen MF, Ossenkoppele GJ, Holman R, van de Loosdrecht AA.

Eur J Cancer. 2014 Dec;50(18):3198-205. doi: 10.1016/j.ejca.2014.09.016. Epub 2014 Oct 28.

PMID:
25454415

Supplemental Content

Loading ...
Support Center